Neuro65/AOCN2024

Presentation information

Print

Hot Topics

English

[HT-02] Hot Topics 02「Disease modifying treatment and promissing biomarkers in primary tauopathies」

Wed. May 29, 2024 9:50 AM - 11:50 AM Room7 (Hall D5, D Block, 5F, TIF)

Chair(s): Hidefumi Ito (Department of Neurology, Wakayama Medical University, Japan), Ikuko Aiba (Department of Neurology, National Hospital Organization Higashinagoya National Hospital, Japan)

[HT-02-2] Development of tau-directed therapies for progressive supranuclear palsy

Yasuo Toda (Japan Clinical Development and Pharmacology, Biogen Japan Ltd., Japan)

photo
1998: Graduated from Keio University School of Medicine
2004: Completed neurosurgical residency at Keio University and its affiliate hospitals
2005: Staff Neurosurgeon, Hiratsuka City Hospital (2006 - Neurosurgeon-in Chief)
2008: Senior Staff Neurosurgeon, Saiseikai Utsunomiya Hospital
2009: Clinical Research Center, Eisai Co., Ltd.
2010: Clinical Research Physician, Bristol-Myers K.K.
2014: CNS Senior Medical Advisor, Medical Affairs, MSD K.K.
2017: Associate Medical Director, Biogen Japan Ltd.
2021: Head of Japan Clinical Development and Pharmacology, Biogen Japan Ltd.

Abstract password authentication.
You can find the password on page 15 of the program book.

Password